ProfileGDS4718 / 225439_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 76% 65% 79% 73% 75% 95% 96% 79% 76% 77% 78% 76% 95% 97% 95% 85% 76% 97% 94% 88% 77% 77% 76% 81% 82% 96% 76% 91% 75% 93% 89% 93% 66% 76% 95% 92% 95% 80% 78% 81% 79% 95% 87% 96% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.4451176
GSM549102patient 115, normal, homogenized [OPG study]6.4604165
GSM549104patient 119, normal, homogenized [OPG study]7.8650579
GSM549108patient 138, normal, homogenized [OPG study]7.1214773
GSM549119patient 077, normal, homogenized [OPG study]7.2250475
GSM549133patient 032, cancer, homogenized [OPG study]10.407695
GSM549139patient 042, cancer, homogenized [OPG study]10.610196
GSM549099patient 107, normal, homogenized [OPG study]7.6955579
GSM549109patient 139, normal, homogenized [OPG study]7.3638676
GSM549110patient 046, normal, homogenized [OPG study]7.5309177
GSM549114patient 063, normal, homogenized [OPG study]7.6816378
GSM549122patient 082, normal, homogenized [OPG study]7.4111776
GSM549134patient 033, cancer, homogenized [OPG study]10.10395
GSM549136patient 036, cancer, homogenized [OPG study]10.912997
GSM549140patient 044, cancer, homogenized [OPG study]10.225495
GSM549111patient 047, normal, homogenized [OPG study]8.5068685
GSM549113patient 057, normal, homogenized [OPG study]7.4517276
GSM549132patient 031, cancer, homogenized [OPG study]10.707697
GSM549137patient 038, cancer, homogenized [OPG study]9.8218694
GSM549142patient 047, cancer, homogenized [OPG study]8.508888
GSM549100patient 110, normal, homogenized [OPG study]7.4565477
GSM549107patient 135, normal, homogenized [OPG study]7.5490177
GSM549115patient 068, normal, homogenized [OPG study]7.5411776
GSM549116patient 072, normal, homogenized [OPG study]8.0255981
GSM549120patient 078, normal, homogenized [OPG study]8.0973982
GSM549131patient 030, cancer, homogenized [OPG study]10.4396
GSM549118patient 074, normal, homogenized [OPG study]7.4624376
GSM549129patient 027, cancer, homogenized [OPG study]9.2470491
GSM549123patient 088, normal, homogenized [OPG study]7.3498275
GSM549124patient 006, cancer, homogenized [OPG study]9.6024193
GSM549126patient 015, cancer, homogenized [OPG study]8.9674889
GSM549128patient 025, cancer, homogenized [OPG study]9.7146893
GSM549103patient 117, normal, homogenized [OPG study]6.5604466
GSM549117patient 073, normal, homogenized [OPG study]7.4503676
GSM549138patient 041, cancer, homogenized [OPG study]10.349695
GSM549141patient 045, cancer, homogenized [OPG study]9.6113792
GSM549130patient 028, cancer, homogenized [OPG study]9.9429795
GSM549101patient 111, normal, homogenized [OPG study]7.7905380
GSM549105patient 128, normal, homogenized [OPG study]7.5656278
GSM549106patient 134, normal, homogenized [OPG study]8.1624781
GSM549112patient 048, normal, homogenized [OPG study]7.7943579
GSM549125patient 011, cancer, homogenized [OPG study]10.21495
GSM549127patient 024, cancer, homogenized [OPG study]8.7351387
GSM549135patient 035, cancer, homogenized [OPG study]10.661196